Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)

v3.19.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2017   14,910    
Beginning balance at Dec. 31, 2017 $ 219,493 $ 10,823 $ 100,456 $ 108,214
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (5,296)     (5,296)
Vesting of restricted stock (in shares)   133    
Vesting of restricted stock (787) $ (79) (708)  
Stock-based compensation expense 676 $ 69 607  
Ending balance (in shares) at Mar. 31, 2018   15,043    
Ending balance at Mar. 31, 2018 214,086 $ 10,813 100,355 102,918
Beginning balance (in shares) at Dec. 31, 2017   14,910    
Beginning balance at Dec. 31, 2017 219,493 $ 10,823 100,456 108,214
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (15,696)      
Ending balance (in shares) at Sep. 30, 2018   15,044    
Ending balance at Sep. 30, 2018 205,136 $ 10,957 101,661 92,518
Beginning balance (in shares) at Mar. 31, 2018   15,043    
Beginning balance at Mar. 31, 2018 214,086 $ 10,813 100,355 102,918
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss 549     549
Stock-based compensation expense 755 $ 75 680  
Ending balance (in shares) at Jun. 30, 2018   15,043    
Ending balance at Jun. 30, 2018 215,390 $ 10,888 101,035 103,467
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (10,949)     (10,949)
Vesting of restricted stock (in shares)   1    
Vesting of restricted stock (8)   (8)  
Stock-based compensation expense 703 $ 69 634  
Ending balance (in shares) at Sep. 30, 2018   15,044    
Ending balance at Sep. 30, 2018 $ 205,136 $ 10,957 101,661 92,518
Beginning balance (in shares) at Dec. 31, 2018 15,090 15,090    
Beginning balance at Dec. 31, 2018 $ 201,100 $ 11,021 102,243 87,836
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (3,042)     (3,042)
Vesting of restricted stock (in shares)   146    
Vesting of restricted stock (714) $ (71) (643)  
Stock-based compensation expense 560 $ 56 504  
Ending balance (in shares) at Mar. 31, 2019   15,236    
Ending balance at Mar. 31, 2019 $ 197,904 $ 11,006 102,104 84,794
Beginning balance (in shares) at Dec. 31, 2018 15,090 15,090    
Beginning balance at Dec. 31, 2018 $ 201,100 $ 11,021 102,243 87,836
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (15,069)      
Ending balance (in shares) at Sep. 30, 2019 15,236 15,263    
Ending balance at Sep. 30, 2019 $ 187,044 $ 11,123 103,154 72,767
Beginning balance (in shares) at Mar. 31, 2019   15,236    
Beginning balance at Mar. 31, 2019 197,904 $ 11,006 102,104 84,794
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (5,248)     (5,248)
Stock-based compensation expense 786 $ 79 707  
Ending balance (in shares) at Jun. 30, 2019   15,236    
Ending balance at Jun. 30, 2019 193,442 $ 11,085 102,811 79,546
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (6,779)     (6,779)
Vesting of restricted stock (in shares)   27    
Vesting of restricted stock (81) $ (8) (73)  
Stock-based compensation expense $ 462 $ 46 416  
Ending balance (in shares) at Sep. 30, 2019 15,236 15,263    
Ending balance at Sep. 30, 2019 $ 187,044 $ 11,123 $ 103,154 $ 72,767